FOXC2-AS1

ncRNA information

ncRNA name

FOXC2-AS1

Specific or universal ncRNAs

Specific ncRNAs

Class

Long noncoding RNA

Biomarker

No

Biomarker application

Upstream regulatory factors

Not available

Downstream target

FOXC2

Cancer information

Cancer name

Osteosarcoma

Cancer site

Bone, Articular Cartilage

Treatment information

Treatment type

Chemotherapy

Drug

Doxorubicin

Impact of wild-type ncRNA on chemotherapy resistance

Up

Impact of knockdown of ncRNA on chemotherapy resistance

Impact of overexpression of ncRNA on chemotherapy resistance

Clinical Information

ncRNA differential expression in
cancer patients vs. healthy people

Not available

Number of patients

68

Male patients

50

Female patients

18

Age range and number

Not available

Research information

PMID

Description

Antisense lncRNA FOXC2-AS1 promotes doxorubicin resistance in osteosarcoma by increasing the expression of FOXC2.

Tissue resource

primary osteosarcoma tissues

human osteosarcoma cell lines MG63

human osteosarcoma cell lines SaoS2

human osteosarcoma cell lines HOS

Experiment

qRT-PCR,Western blot


Institute

the Shanghai Tenth Hospital

American Type Culture Collection

Country

China

USA

Continent

Asia

Amercia